Crossmark

Evaluation of the cost-utility of phosphate binders as a treatment option for hyperphosphatemia in chronic kidney disease patients: a systematic review and meta-analysis of the economic evaluations

Crossref DOI link: https://doi.org/10.1007/s10198-021-01275-3

Published Online: 2021-03-06

Published Print: 2021-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chaiyakittisopon, Kamolpat

Pattanaprateep, Oraluck https://orcid.org/0000-0001-9570-2635
Ruenroengbun, Narisa

Sapankaew, Tunlanut

Ingsathit, Atiporn

Mckay, Gareth J.

Attia, John

Thakkinstian, Ammarin
License Information

Text and Data Mining valid from 2021-03-06

Version of Record valid from 2021-03-06
More Information

Article History

Received: 21 August 2020

Accepted: 18 February 2021

First Online: 6 March 2021

Declarations

:

: All authors declared no conflict of interest.

Document is current

Any future updates will be listed below